Patheon Inc., a leading provider of contract development and manufacturing services for the global pharmaceutical industry, is pleased to announce that Michael Lehmann, President, global PDS and interim executive vice president, global sales and marketing, has been named in the 2013 PharmaVOICE 100, an annual list published by PharmaVOICE Magazine, which recognizes top individuals for their positive contributions to the life sciences industry.
Mr. Lehmann is a pharmaceutical executive who has dedicated 25 years of his career to helping improve the lives of patients, while bringing innovative offerings to meet and exceed his customers’ challenges.
At Patheon, he is responsible for the global pharmaceutical development services (PDS) business, in which Patheon holds the leading market position. The PDS business offers customers a broad range of development services, enabling clients to move through early development all the way to commercial manufacturing.
"I am truly honored to be named to the PharmaVOICE 100 list and be among the top leaders in the life sciences industry," said Michael Lehmann.
"It not only reinforces the positive impact that we as leaders can have in our industry, but also the successful work we are doing here at Patheon, where we believe it is our responsibility to serve our customers and provide them with the industry’s leading customer experience."
Established nine years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. These individuals illustrate what it means to think bigger, do more and lead with passion and integrity.
The distinguished honorees are nominated by thousands of PharmaVOICE readers throughout the year and are selected based on well-crafted and comprehensive essays, describing how they have inspired or motivated their colleagues, peers and even competitors and how they have brought positive changes in their own organizations; as well as other factors, such as community and philanthropic activities.
PharmaVOICE 100 honorees represent a broad cross-section of industry sectors, including pharmaceutical, biopharmaceutical, biotechnology, contract research, clinical trial, research and development, patient education, patient recruitment, advertising, marketing, technology, training, mentoring and many others.